While I am at it the co announced today funds will also be put towards and to commence planning for a proof of principle clinical trial in another disease indication such as Lupus,psoriasis etc etc
The Lupus market alone is estimated to be $4B by 2012;I beleive the leader of the market is currently Human Genome Sciences with a market M/Cap of $5.18B.
Xtoll could also be used to treat
Psoriasis ?C Market est. $4.1B by 2015
Psoriatic arthritis ?C Market est. $4B 2012
Other ??Orphan Indications?? ?C attract government re?\imbursement of up to $0.5 million per patient.
CBZ Price at posting:
50.6¢ Sentiment: Buy Disclosure: Held